Menu

Featured News

Some of the leading stories and synthetic biology information from SynbiCITE

SynbiTECH2020 - Sponsor or Exhibit?

Happy new year! 2020 is the start of a new decade in which synthetic biology will thrive and grow – by 2030 we expect the global marketplace to be at ...

Read article

Kick off 2020 with a bang!

Don't miss our SUPER EARLY BIRD offer, ending 31st January! "Pretty much everyone we were looking to connect with in the synthetic biology and indust...

Read article

Synthetic Biology community

Take a look at the active and interactive synthetic biology community. Join the conversation and get involved.
Bristol Biodesign 2020

6 May 2020

View event
SynbiTECH2020 - Sponsor or Exhibit?

Happy new year! 2020 is the start of a new decade in which synthetic biology will thrive and grow – by 2030 we expect the global marketplace to be at ...

Read article
The Cell Factories of the Future

Professor Paul Freemont, Co-Director of SynbiCITE, is the lead author of a recent article published by the World Economic Forum on this subject, entitled “How scientists are turning living cells into the tiny factories of the future”.

Read article
Evonetix collaborates with imec to scale-up chip-based technology production for third generation DNA synthesis platform

CAMBRIDGE, UK, and LEUVEN, Belgium, 13 January 2020 – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scala...

Read article
Kick off 2020 with a bang!

Don't miss our SUPER EARLY BIRD offer, ending 31st January! "Pretty much everyone we were looking to connect with in the synthetic biology and indust...

Read article
SynbiTECH 2020 - Register your interest

SynbiTECH will return to London on 6-7th July 2020!To be kept up to date on ticket sales and conference announcements please register your interest he...

Read article
Macrophage Pharma Expands Executive Team with Chief Scientific Officer and Chief Technology Officer

Macrophage Pharma Limited ("MPL"), a biotech company focused on the discovery and development of next-generation immunomodulatory small molecules indu...

Read article
The SynbiCITE ‘4-Day MBA, More Business Acumen’ Course

The SynbiCITE ‘4-Day MBA: More Business Acumen’ Course, 8th-12th December 2019In 2015, 35% of employers in engineering and technology-based business s...

Read article
Prokarium secures £4.6m Wellcome funding for Entervax

Prokarium has announced an investment of £4.59 million from Wellcome to fund two clinical trials of its lead programme, Entervax.Follow this link for ...

Read article
Biotech firm MiAlgae secures £1m to turn whisky by-products into pet and fish food

An Edinburgh-based biotech startup which turns whisky distillation by-products into pet and fish food has received investment of £1 million.MiAlgae pr...

Read article
Data-driven design and the opportunities it presents for biotech companies

Professor Paul Freemont, Co-Director of SynbiCITE, discussed the synthetic biology industry and the opportunities it is creating in a recently paper published in The Emerging Topics in Life Sciences entitled “Synthetic biology industry: data-driven design is creating new opportunities in biotechnology”.

Read article
SynbiTECH conference gets up close and personal with the synbio companies powering the uk bioeconomy

SynbiTECH 2019 is the only international conference focused on synthetic biology taking place in the UK in 2019, designed for senior business leaders from start-ups to multinationals, investors and policy makers.

Read blog article